Related Experiment Video
Updated: Aug 6, 2026
10:18
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
14.3K
HTLV-1 and Adult T-Cell Leukemia/Lymphoma: A Review
F Ravandi-Kashani1, C Sriswasdi1, A Lynott2
1a Department of Leukemia , University of Texas , M.D. Anderson Cancer Center , Houston , Texas.
Hematology (Amsterdam, Netherlands)
|July 16, 2016
Summary
Human T-lymphotropic virus type 1 (HTLV-1) causes Adult T-cell Leukemia/Lymphoma (ATL). Promising new treatments like adenosine analogs and interferons are emerging for this diverse and increasingly reported malignancy.
Area of Science:
- Hematology
- Virology
- Oncology
Background:
- Adult T-cell Leukemia/Lymphoma (ATL) is fundamentally linked to human T-lymphotropic virus type 1 (HTLV-1) infection.
- ATL is endemic in certain regions but is increasingly diagnosed globally.
- Clinical presentations of ATL exhibit significant diversity.
Purpose of the Study:
- To review the etiology, clinical diversity, and evolving treatment strategies for Adult T-cell Leukemia/Lymphoma.
- To highlight recent advancements in ATL therapy.
Main Methods:
- Review of current literature on HTLV-1 and ATL.
- Analysis of treatment outcomes from recent clinical trials.
Main Results:
- Traditional chemotherapy has shown limited success in ATL treatment.
- Emerging therapies including adenosine analogs, interferons, and AZT combinations demonstrate therapeutic promise.
- Understanding the molecular basis of ATL is advancing.
Conclusions:
- Effective therapies for ATL are anticipated with deeper insights into its etiology and molecular mechanisms.
- The evolving landscape of ATL treatment offers hope for improved patient outcomes.
Related Concept Videos
01:27Disorders of Leukocytes
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune system...
01:18Lymphoid Cells and Tissues
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
01:23Cells of the Adaptive Immune Response
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...